Valeo | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Valeo
US Exclusivities

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

dmfs-not-supported-m-2025-06-16

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-06-09

Valeo

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 7 USDMF, 4 CEP/COS, 2 JDMF, 4 EU WC, 9 NDC API, 14 Listed Suppliers, $ API Reference Price

23 API Suppliers
7 USDMF
4 CEP/COS
2 JDMF
4 EU WC
9 NDC API
14 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

34 Drugs in Development

34 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

362 FDF Dossiers, 129 FDA Orange Book, 129 Europe, 15 Canada, 31 Australia, 18 South Africa, 40 Listed Dossiers

362 FDF Dossiers
129 FDA Orange Book
129 Europe
15 Canada
31 Australia
18 South Africa
40 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 2MG, TABLET;ORAL - 5MG, GEL;RECTAL - 10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;RECTAL - 15MG/3ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;RECTAL - 2.5MG/0.5ML (5MG/ML), GEL;RECTAL - 20MG/4ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;RECTAL - 5MG/ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG
TABLET;ORAL - 2MG
TABLET;ORAL - 5MG
GEL;RECTAL - 10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;RECTAL - 15MG/3ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;RECTAL - 2.5MG/0.5ML (5MG/ML)
GEL;RECTAL - 20MG/4ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;RECTAL - 5MG/ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 6 SPI Pharma, 3 DKSH, 5 Faran Shimi Pharmaceutical, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 4 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 2 Clariant, 10 Corel Pharma Chem, 7 DFE Pharma, 3 Finar, 6 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 27 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 5 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 5 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 26 Disintegrants & Superdisintegrants, 25 Controlled & Modified Release, 20 Direct Compression, 20 Thickeners and Stabilizers, 19 Granulation, 18 Lubricants & Glidants, 17 Film Formers & Plasticizers, 16 Topical, 16 Co-Processed Excipients, 13 Taste Masking, 9 Solubilizers, 8 Chewable & Orodispersible Aids, 7 Parenteral, 6 Emulsifying Agents, 6 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 2 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

60 Fillers, Diluents & Binders
46 Coating Systems & Additives
26 Disintegrants & Superdisintegrants
25 Controlled & Modified Release
20 Direct Compression
20 Thickeners and Stabilizers
19 Granulation
18 Lubricants & Glidants
17 Film Formers & Plasticizers
16 Topical
16 Co-Processed Excipients
13 Taste Masking
9 Solubilizers
8 Chewable & Orodispersible Aids
7 Parenteral
6 Emulsifying Agents
6 Rheology Modifiers
5 Empty Capsules
4 Vegetarian Capsules
4 API Stability Enhancers
2 Surfactant & Foaming Agents
2 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 73 News #PharmaBuzz

1 Data Compilation #PharmaFlow
73 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 136 Regulatory FDF Prices, 3 Annual Reports

4 US Medicaid Prescriptions
136 Regulatory FDF Prices
3 Annual Reports

MARKET PLACE

31 APIs, 24 FDF Dossiers

31 APIs
24 FDF Dossiers

PATENTS & EXCLUSIVITIES

24 US Patents, 6 US Exclusivities, 1 Health Canada Patents

24 US Patents
6 US Exclusivities
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 10 Others

2 EDQM
10 Others

$ API Ref.Price (USD/KG) : 272 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

6 All

01 6NEURELIS INC

filter Product Reset all filters

6 All

01 6DIAZEPAM

filter Exclusivity Expiration Date Reset all filters

6 All

01 32027-01-10

02 32028-04-15

filter Exclusivity Code Reset all filters

6 All

01 3NPP

02 3ODE-279

Product Main Page

NEURELIS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DIAZEPAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-279

Exclusivity Expiration Date

2027-01-10

Application Number

211635

Product Number

3

Exclusivity Details

01

NEURELIS INC

ACS GCI

Not Confirmed

NEURELIS INC

U.S.A

ACS GCI

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE-279

Exclusivity Expiration Date : 2027-01-10

Application Number : 211635

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

NEURELIS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DIAZEPAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2028-04-15

Application Number

211635

Product Number

3

Exclusivity Details

02

NEURELIS INC

ACS GCI

Not Confirmed

NEURELIS INC

U.S.A

ACS GCI

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : NPP

Exclusivity Expiration Date : 2028-04-15

Application Number : 211635

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

NEURELIS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DIAZEPAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-279

Exclusivity Expiration Date

2027-01-10

Application Number

211635

Product Number

2

Exclusivity Details

03

NEURELIS INC

ACS GCI

Not Confirmed

NEURELIS INC

U.S.A

ACS GCI

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE-279

Exclusivity Expiration Date : 2027-01-10

Application Number : 211635

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

NEURELIS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DIAZEPAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2028-04-15

Application Number

211635

Product Number

2

Exclusivity Details

04

NEURELIS INC

ACS GCI

Not Confirmed

NEURELIS INC

U.S.A

ACS GCI

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : NPP

Exclusivity Expiration Date : 2028-04-15

Application Number : 211635

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

NEURELIS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DIAZEPAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-279

Exclusivity Expiration Date

2027-01-10

Application Number

211635

Product Number

1

Exclusivity Details

05

NEURELIS INC

ACS GCI

Not Confirmed

NEURELIS INC

U.S.A

ACS GCI

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : ODE-279

Exclusivity Expiration Date : 2027-01-10

Application Number : 211635

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

NEURELIS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DIAZEPAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2028-04-15

Application Number

211635

Product Number

1

Exclusivity Details

06

NEURELIS INC

Nephrology & Therapeutics

Not Confirmed

NEURELIS INC

U.S.A

Nephrology & Therapeutics

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : NPP

Exclusivity Expiration Date : 2028-04-15

Application Number : 211635

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!